Development of a high-throughput bioassay to determine the rate of antimalarial drug action using fluorescent vitality probes
Malaria is one of the most prevalent diseases in Africa and the Plasmodium falciparum species is widely accepted as the most virulent, with a fatality rate of 15 – 20 % of reported cases of infection. While various treatments have been accepted into early stage clinical trials there has been little...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Rhodes University
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10962/64434 |